BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 38575221)

  • 1. Pharmacologic Management of Eosinophilic Esophagitis.
    Falk GW; Pesek R
    Immunol Allergy Clin North Am; 2024 May; 44(2):245-264. PubMed ID: 38575221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eosinophilic Gastrointestinal Disorders.
    Fahey LM; Liacouras CA
    Pediatr Clin North Am; 2017 Jun; 64(3):475-485. PubMed ID: 28502433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Evaluation of the Child with Eosinophilic Esophagitis.
    Bauer M; Nguyen N; Liacouras CA
    Immunol Allergy Clin North Am; 2024 May; 44(2):157-171. PubMed ID: 38575215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diagnosis and Treatment of Eosinophilic Esophagitis].
    Kim SJ; Choi CW; Hwang CS
    Korean J Gastroenterol; 2022 Mar; 79(3):99-108. PubMed ID: 35342167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eosinophilic Esophagitis: Incidence, Diagnosis, Management, and Future Directions.
    Fernandez-Becker NQ
    Gastroenterol Clin North Am; 2021 Dec; 50(4):825-841. PubMed ID: 34717873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proton pump inhibitor treatment decreased duodenal and esophageal eosinophilia in a case of eosinophilic gastroenteritis.
    Yamada Y; Toki F; Yamamoto H; Nishi A; Kato M
    Allergol Int; 2015 Sep; 64 Suppl():S83-5. PubMed ID: 26344087
    [No Abstract]   [Full Text] [Related]  

  • 7. [Current real-world treatments for Japanese patients with eosinophilic esophagitis].
    Fujiwara Y; Tanaka F; Nakata R; Kakiya Y; Yamamura M; Tanoue K; Sawada A; Higashimori A; Nishida Y; Maruyama H; Ominami M; Nadatani Y; Fukunaga S; Otani K; Hosomi S; Kamata N; Nagami Y; Taira K
    Nihon Shokakibyo Gakkai Zasshi; 2022; 119(10):929-936. PubMed ID: 36216543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Responses of Proton Pump Inhibitors and Potassium-Competitive Acid Blockers According to Outcomes of Symptom, Endoscopy, and Histology in Patients With Eosinophilic Esophagitis.
    Fujiwara Y; Sawada A; Ominami M; Fukunaga S; Otani K; Hosomi S; Nagami Y; Taira K; Tanaka F
    J Clin Gastroenterol; 2024 Apr; 58(4):337-341. PubMed ID: 37267311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of a Second PPI Course After Steroid-Induced Remission in Eosinophilic Esophagitis Refractory to Initial PPI Therapy.
    Visaggi P; Baiano Svizzero F; Del Corso G; Bellini M; Savarino E; de Bortoli N
    Am J Gastroenterol; 2022 Oct; 117(10):1702-1705. PubMed ID: 36087067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eosinophilic esophagitis: from pathophysiology to management.
    Ghisa M; Laserra G; Maniero D; Marabotto E; Barberio B; Pelizzaro F; Barbuscio I; Zingone F; Savarino V; Savarino E
    Minerva Gastroenterol (Torino); 2022 Mar; 68(1):40-48. PubMed ID: 33267562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biological therapies for eosinophilic gastrointestinal diseases.
    Wechsler JB; Hirano I
    J Allergy Clin Immunol; 2018 Jul; 142(1):24-31.e2. PubMed ID: 29859203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging drugs for eosinophilic esophagitis.
    Pesek RD; Gupta SK
    Expert Opin Emerg Drugs; 2018 Jun; 23(2):173-183. PubMed ID: 29848130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Eosinophilic oesophagitis in children].
    Nielsen MH; Bredal K; Terkelsen JH; Kristiansen DM; Krarup AL
    Ugeskr Laeger; 2022 Aug; 184(31):. PubMed ID: 35959825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of Eosinophilic Esophagitis: Diet or Medication?
    Chehade M; Aceves SS
    J Allergy Clin Immunol Pract; 2021 Sep; 9(9):3249-3256. PubMed ID: 34507706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacologic Treatment of Eosinophilic Esophagitis: An Update.
    Schoepfer AM; Straumann A; Safroneeva E
    Gastrointest Endosc Clin N Am; 2018 Jan; 28(1):77-88. PubMed ID: 29129301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical, histopathological features and efficacy of elimination diet and proton-pump inhibitor therapy in achieving histological remission in Asian children with eosinophilic gastritis.
    Ng LQ; Loh W; Ong JX; Merchant K; Chiou FK
    J Paediatr Child Health; 2022 Jul; 58(7):1244-1250. PubMed ID: 35388934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eosinophilic esophagitis in children: Multicenter retrospective study in an Italian cohort.
    Barni S; Pessina B; Scarallo L; Renzo S; Pieri ES; Labriola F; Alvisi P; Villanacci V; Giovannini M; Sarti L; Tomei L; Barp J; Naldini S; Paci M; Mori F; Lionetti P
    Clin Exp Allergy; 2024 Mar; 54(3):225-227. PubMed ID: 38262705
    [No Abstract]   [Full Text] [Related]  

  • 18. Biologic Therapies Targeting Eosinophilic Gastrointestinal Diseases.
    Oshima T
    Intern Med; 2023 Dec; 62(23):3429-3430. PubMed ID: 37081678
    [No Abstract]   [Full Text] [Related]  

  • 19. Drug treatment strategies for eosinophilic esophagitis in adults.
    Lucendo AJ
    Expert Opin Pharmacother; 2022 May; 23(7):827-840. PubMed ID: 35379069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are the Proton Pump Inhibitor-Responsive and -Nonresponsive Phenotypes of Eosinophilic Esophagitis Exactly the Same?
    Gómez Torrijos E; Castro Jimenez A; Gratacós Gómez AR; González Jimenez OM; Joyanes Romo JB; Feo Brito F; Urra Ardanaz JM; Garcia Rodriguez R
    J Investig Allergol Clin Immunol; 2021 Oct; 31(5):441-442. PubMed ID: 34710050
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.